Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.72285
+0.0329 (4.76%)
Aug 14, 2026, 3:12 PM EDT - Market open
Adagio Medical Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
16.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | -81.00K | -30.00% |
| Dec 31, 2021 | 270.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 52.58M |
| Trinity Biotech | 43.79M |
| Cytosorbents | 37.22M |
| Lifeward | 20.92M |
| NeuroOne Medical Technologies | 12.72M |
| Pulsenmore | 12.55M |
| IceCure Medical | 3.95M |
| Co-Diagnostics | 718.17K |
ADGM News
- 3 days ago - Adagio Medical Reports Second Quarter 2026 Results - Business Wire
- 3 days ago - Adagio Medical Holdings Quarterly report: Q2 2026 - Filings
- 3 days ago - Adagio Medical Holdings Earnings release: Q2 2026 - Filings
- 11 days ago - Adagio Medical treats first patient with vCLAS Ultra ULTA system - TheFly
- 11 days ago - Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire
- 2 months ago - Adagio Medical Holdings Transcript: AGM 2026 - Transcripts
- 2 months ago - Adagio Medical initiated with a Buy at Lucid Capital - TheFly
- 3 months ago - Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation - TheFly